Predictors of early death in a cohort of Ethiopian patients treated with HAART. - Wikidata - awgldk - TriplyDB

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

http://www.wikidata.org/entity/Q33256138

about

High early mortality in patients with chronic acquired immunodeficiency syndrome diarrhea initiating antiretroviral therapy in Haiti: a case-control study Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in Far-western region, 2006-2011 Changing predictors of mortality over time from cART start: implications for care.Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort study Predictors of Survival among Adult Ethiopian Patients in the National ART Program at Seven University Teaching Hospitals: A Prospective Cohort Study Effects of nutrition counseling and monitoring on the weight and hemoglobin of patients receiving antiretroviral therapy in Ebonyi State, Southeast Nigeria.Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia.The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study.Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis.Prevalence and Risk Factors of Mortality among Adult HIV Patients Initiating ART in Rural Setting of HIV Care and Treatment Services in North Western Tanzania: A Retrospective Cohort Study Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program.Association of pre-treatment nutritional status with change in CD4 count after antiretroviral therapy at 6, 12, and 24 months in Rwandan women.Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia Lactation-associated postpartum weight changes among HIV-infected women in Zambia.Factors associated with mortality in HIV-infected people in rural and urban South Africa.Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART.Characteristics and predictors of death among hospitalized HIV-infected patients in a low HIV prevalence country: Bangladesh Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study Effects of highly active antiretroviral therapy on the survival of HIV-infected adult patients in urban slums of Kenya.High-nutrition biscuits to increase animal protein in diets of HIV-infected Kenyan women and their children: a study in progress Development and validation of a clinical score for prognosis stratification in patients requiring antiretroviral therapy in sub-Saharan Africa: a prospective open cohort study.Utilization of antiretroviral treatment in Ethiopia between February and December 2006: spatial, temporal, and demographic patterns.Correlates of Strengthening Lessons from HIV/AIDS Treatment and Care Services in Ethiopia Perceived Access and Implications for Health System.Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study.High Initial HIV/AIDS-Related Mortality and -Its Predictors among Patients on Antiretroviral Therapy in the Kagera Region of Tanzania: A Five-Year Retrospective Cohort Study Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia High loss to followup and early mortality create substantial reduction in patient retention at antiretroviral treatment program in north-west ethiopia.Self-reported dietary intake and appetite predict early treatment outcome among low-BMI adults initiating HIV treatment in sub-Saharan Africa.Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.Nutritional status and its effect on treatment outcome among HIV infected clients receiving HAART in Ethiopia: a cohort study Mortality and loss to follow-up among HAART initiators in rural South Africa.Effects of Antiretroviral Therapy on the Survival of Human Immunodeficiency Virus-positive Adult Patients in Andhra Pradesh, India: A Retrospective Cohort Study, 2007-2013 Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.Macronutrient supplementation and food prices in HIV treatment.Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study.Nutritional status and mortality among HIV-infected patients receiving antiretroviral therapy in Tanzania.Comparison of treatment adherence outcome among PLHIV enrolled in economic strengthening program with community control.

P2860

Q30414385-A67D8BB3-D39B-478B-B77C-3D4E4DC84351 Q31146660-A60AF366-FCAE-409A-9E0D-99FD23D75F17 Q33564975-56CCBB65-7618-41A0-A77C-14B964CD9937 Q33587556-769E9A97-A4AE-47B3-8125-1E5D573039ED Q33596118-3D07E5DA-0C82-49BE-939A-DC759CC3DAAD Q33670616-06687BF9-5485-4D85-9A0B-93767A1B1807 Q33719226-B50E7861-B25C-4DBA-AFE9-0C9CC1E9D1C6 Q33816036-8582400E-BD11-4CAC-8888-56FC3555EFF7 Q33838306-48228877-FC2D-40EF-9109-28CEFF8A231A Q33862338-401D6573-C0B0-4F63-AB35-97BF6BA6FA54 Q33869315-A738794F-FD36-4BED-89E2-5B79197DF0E7 Q34117813-2BF1D61E-0205-4A03-8DD4-15DE56506C5A Q34119037-6D586949-40C0-4520-8862-60AE86285B82 Q34257244-0EFE1A56-1D82-47AA-A9C6-B3ED0F534FE8 Q34274437-4491A4F2-E23E-44E1-9922-CDAEDD820E88 Q34288554-5696FACE-5464-41DE-AF00-2B475EBA32FB Q34416963-649A3CA5-A979-4DC9-9C27-672CB1C3A9E5 Q34653573-3621394A-DD1E-43C9-8141-796EE91309B4 Q35545908-EECC5910-67CC-4727-B6BD-7973EF423530 Q35668344-701B4B38-6A73-4224-9FFC-25E09A2CFDE0 Q35694127-55A721DB-2ECC-405B-AAAE-2961BCD86485 Q35767307-130D4B90-156F-43C5-8179-43D3B3E31396 Q36099572-2D7C83E1-42E2-429A-93D2-3763B4B34E31 Q36109312-39D943AC-CA04-4DC6-B009-66C6DB2F081D Q36112621-6D8BD919-71DB-4D43-B108-F0384E3B2566 Q36220774-C739ABA5-B55A-4DDB-8985-66DC5127A4C8 Q36546124-F9131CE8-B5AF-4CAA-BC8B-4C3BC21D8CB5 Q37157118-A0E64C54-2A6F-4AE3-9440-717D202E6DBC Q37168183-F5F6E1DC-B6AF-4C64-BFA4-F5DD4EBA60A3 Q37265947-05DF76FF-3F19-45ED-BA9A-EF104BDADE80 Q37278636-69397E0D-C15C-46AD-B304-3FBE160208D4 Q37326881-F2B5067D-2A32-4472-8870-3F710ABF05B5 Q37509151-BE60C794-B519-4F1E-A802-DF62819997D7 Q37578947-A44AB6A2-FA29-4535-910B-F2C681EBC4BE Q37638942-A176743C-4D94-4A27-8E8E-3437D9DBF232 Q39678239-ED04E2E8-96E3-49ED-94AA-009EC6AEEB51 Q43940315-E50254EE-BD7F-4AB2-BEAB-8AF4C8422A95 Q48674990-C9C67005-F9FE-42F7-A4F9-FAE64B8363DC

P2860

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

http://www.wikidata.org/entity/Q33256138

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

@ast

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

@en

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

@nl

type

label

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

@ast

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

@en

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

@nl

prefLabel

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

@ast

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

@en

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

@nl

P1433

Q33256138-A6902A03-7783-48EE-9413-70818506C90E

P1476

Q33256138-1304AFB6-5FAE-4EA9-A1DA-7EEBB87A01DF

P2093

Q33256138-8A681971-D901-4C44-8A84-F3B68B7795B9

Q33256138-8BED095A-A299-4CCE-875C-9AB2EBCD8272

Q33256138-B1FE8275-765A-49FD-BB4D-D4B1B5ADD668

P2860

Q33256138-046550C8-2715-45B1-BEEB-C8D35179DEDE

Q33256138-072EA614-AE9C-49F4-AA22-0FB971D1C7BE

Q33256138-0DDC567F-6D4D-46FD-BE11-22715501E6A9

Q33256138-257253B3-239A-4567-AC92-C1F6CB42FF44

Q33256138-263AF72E-E1A1-4901-A113-1866FEB384AE

Q33256138-35FB8D14-62D3-4340-BF4D-6A68F62DDAC7

Q33256138-44657370-4E31-4B23-991A-93F661413D4E

Q33256138-485A93B1-DB73-433D-A3F7-0CA39EB3088C

Q33256138-6BD51A24-36C6-4181-8A53-5D1159043901

Q33256138-74AFEB2F-E383-46E1-9F04-8F8D7720D8D0

P2888

Q33256138-283F4E47-21E0-4037-A558-507506F9AD4A

P304

Q33256138-FD2EE5F0-3252-4605-B777-C8889BFC2205

P31

Q33256138-7DCD50AB-1B5A-431A-B584-499CA6EC8A4C

P356

Q33256138-DD51BA98-A812-4EFD-84D4-5959EBEF1697

P478

Q33256138-E453F6B4-2BAE-4959-8284-3241E8076F86

P50

Q33256138-2C8326E4-B2CA-4FC0-ADA4-749BB729EEF6

P577

Q33256138-2A5F6175-BD71-4E6F-A497-E9155A195173

P5875

Q33256138-6046E601-32D7-4DA8-BC05-EA87FF773844

P6179

Q33256138-E816B301-F08C-4C1C-92EB-D23251F2E076

P698

Q33256138-7F3DAF1E-2289-491E-847A-C884E73432B8

P921

Q33256138-2A5049F4-1704-43CD-92A3-15916CB5556B

Q33256138-C4A0613B-FF4F-4F46-9175-757C0134A383

P932

Q33256138-A3D17C1A-28D0-4EAE-838D-34B6FCB2DD2A

P356

1471-2334-6-136

P1433

BMC Infectious Diseases

P1476

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

@en

P2093

Aschalew Endale

http://www.w3.org/2001/XMLSchema#string

Degu Jerene

http://www.w3.org/2001/XMLSchema#string

Yewubnesh Hailu

http://www.w3.org/2001/XMLSchema#string

P2860

Interim proposal for a WHO Staging System for HIV infection and Disease

Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients.

Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003.

A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries.

HIV counseling and testing practices at an urban hospital in Kampala, Uganda.

Antiretroviral therapy in a thousand patients with AIDS in Haiti.

Correlation among total lymphocyte count, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patients.

Body mass index at time of HIV diagnosis: a strong and independent predictor of survival.

Cheaper HIV drugs for poor nations bring a new challenge: monitoring treatment.

Difficulty swallowing and lack of receipt of highly active antiretroviral therapy predict acute weight loss in human immunodeficiency virus disease.

P2888

1471-2334-6-136

P304

136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-6-136

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Bernt Lindtjørn

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6840767

http://www.w3.org/2001/XMLSchema#string

P6179

1042037317

http://www.w3.org/2001/XMLSchema#string

P698

16948852

http://www.w3.org/2001/XMLSchema#string

P921

P932

1569839

http://www.w3.org/2001/XMLSchema#string